PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Prescription Drugs	705.23B	708.42B	638.67B	660.42B	632.28B
Prescription Drugs Growth	-0.45%	10.92%	-3.29%	4.45%	2.85%
Services	26.51B	26.98B	-	-	-
Services Growth	-1.76%	-	-	-	-
Consumer Health Products	1.15T	961.78B	1.06T	942.75B	845.97B
Consumer Health Products Growth	20.02%	-9.03%	12.15%	11.44%	11.88%
Export & Toll Manufacturing	201.58B	193.70B	221.12B	297.72B	351.45B
Export & Toll Manufacturing Growth	4.06%	-12.40%	-25.73%	-15.29%	-20.50%
Total	2.09T	1.89T	1.92T	1.90T	1.83T
Total Growth	10.40%	-1.36%	0.85%	3.89%	0.92%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Indonesia	1.90T	1.72T	1.71T	1.65T	1.49T
Indonesia Growth	10.86%	0.21%	4.18%	10.39%	6.34%
Export	183.26B	173.13B	202.97B	255.64B	339.27B
Export Growth	5.85%	-14.70%	-20.60%	-24.65%	-17.54%
Total	2.09T	1.89T	1.92T	1.90T	1.83T
Total Growth	10.40%	-1.36%	0.85%	3.89%	0.92%

Source: S&P Global Market Intelligence.